Stem Cell Therapy in Mental Retardation

NCT02245724•Neurogen Brain and Spine Institute

View on ClinicalTrials.gov

Summary

The purpose of this study was to analyze the benefit of autologous mononuclear cell therapy in mental retardation.

Eligibility

Age

0 - 40 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•diagnosed cases of mental retardation
•age above 6 months

Exclusion Criteria

•presence of acute infections such as Human immunodeficiency virus/Hepatitis B Virus/Hepatitis C Virus
•malignancies
•bleeding tendencies
•pneumonia
•renal failure
•severe liver dysfunction
•severe anemia \[Hemoglobin \< 8\]
•any bone marrow disorder
•space occupying lesion in brain
•other acute medical conditions such as respiratory infection and pyrexia

Locations (1)

Neurogen brain and spine institute

Navi Mumbai, Maharashtra, India

Key Dates

Start Date

September 1, 2011

Primary Completion Date

March 1, 2016

Completion Date

September 1, 2016

Last Updated

October 25, 2018

Conditions

Mental Retardation

Interventions

Stem Cell

BIOLOGICAL

Effects of Different Dual-Task Exercises in Children With Mild Mental Retardation

NCT07028333

Mental Retardation

View study

RECRUITING

Congenital Muscle Disease Study of Patient and Family Reported Medical Information

NCT01403402

Congenital Muscular Dystrophy With ITGA7 (Integrin Alpha-7) DeficiencyAlpha-Dystroglycanopathy (Congenital Muscular Dystrophy and Abnormal Glycosylation of Dystroglycan With Severe Epilepsy)+50 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 25, 2018Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Stem Cell Therapy in Mental Retardation

Inclusion Criteria

Exclusion Criteria

Effects of Different Dual-Task Exercises in Children With Mild Mental Retardation

Congenital Muscle Disease Study of Patient and Family Reported Medical Information

Cognitive Neuroscience of Autism Spectrum Disorders

Neurodevelopment Outcome of Newborns Exposed to Zika Virus (ZIKV) in Utero

European Alpha-Mannosidosis Participant

Exploring the Comorbidity Between Mental Disorders and General Medical Conditions